Abstract:Pathological studies have shown that the vulnerability of plaques affects outcomes in patients with atherosclerosis (AS), a chronic inflammatory disease and common cause of morbidity and mortality worldwide. Although emerging technologies have enabled early diagnosis of AS with high-risk vulnerable plaques, more accurate and noninvasive diagnostic methods are urgently required. To this end, molecules involved in genetic or epigenetic regulation of the vulnerability of atherosclerotic plaques have been extensively studied. Here, we evaluated long noncoding RNA (lncRNA) variability by microarray assay in murine aortic endothelial cells (MAECs) bearing vulnerable plaques and identified the novel functional lncRNA UC.98, whose expression pattern was associated with the vulnerability of atherosclerotic plaques. Consistent with this, clinical statistics comparing the peripheral blood specimens from sets of patients with AS with or without vulnerable plaques confirmed the linear relationship between the expression pattern of UC.98 and plaque instability. Moreover, MTT assays and western blot analysis showed that silencing of intrinsic UC.98 in MAECs not only suppressed cell proliferation but also decreased the expressions of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1, thereby inactivating the nuclear factor-κB pathway. In conclusion, our results highlighted the pivotal role of UC.98 in regulating the vulnerability of plaques during AS progression and suggested that UC.98 may be a biomarker of the early diagnosis and prognosis of AS with vulnerable plaques and a potential therapeutic target for slowing AS progression.

Regulatory Roles of Related Long Non-coding RNAs in the Process of Atherosclerosis

LncRNA: An Important Regulator of Atherosclerosis

Noncoding RNAs in atherosclerosis: regulation and therapeutic potential

Long Noncoding RNAs in Atherosclerosis.

The Combined Regulation of Long Non-coding RNA and RNA-Binding Proteins in Atherosclerosis

The Long Non-coding Road to Atherosclerosis

Non-coding RNAs are key players and promising therapeutic targets in atherosclerosis

Pathological Bases and Clinical Application of Long Noncoding RNAs in Cardiovascular Diseases

LncRNA-mediated Modulation of Endothelial Cells: Novel Progress in the Pathogenesis of Coronary Atherosclerotic Disease

Research progress of long non-coding RNA in the pathogenesis of atherosclerosis

LncRNA-modulated autophagy in plaque cells: a new paradigm of gene regulation in atherosclerosis?

Long Noncoding RNA UC.98 Stabilizes Atherosclerotic Plaques by Promoting the Proliferation and Adhesive Capacity in Murine Aortic Endothelial Cells

Long Non-Coding RNAs Link Oxidized Low-Density Lipoprotein With the Inflammatory Response of Macrophages in Atherogenesis

Differential RNA Expression Profiles and Competing Endogenous RNA-associated Regulatory Networks During the Progression of Atherosclerosis

Role of long non-coding RNA-RNCR3 in atherosclerosis-related vascular dysfunction

Long non-coding RNAs: Modulators of phenotypic transformation in vascular smooth muscle cells

Non-coding RNA-Associated Therapeutic Strategies in Atherosclerosis

Circular RNAs in the Pathogenesis of Atherosclerosis

Microarray profiling analysis and validation of novel long noncoding RNAs and mRNAs as potential biomarkers and their functions in atherosclerosis

Long Noncoding Rna: Recent Updates In Atherosclerosis

Recent advances in the regulation of ABCA1 and ABCG1 by lncRNAs